Safety and ethical consideration of AIDS vaccine.
It has been demonstrated that HIV-1 gp120 resembles several important properties of immunoglobulins allowing it strong influence on the human immune system, especially through induction of the deceptive imprinting and deregulation of the immune network. On the other hand there are many unanswered questions concerning properties and control of the genetically modified viruses and bacteria used as vectors in AIDS vaccines. This situation opens a serious question about the safety of vectored AIDS vaccine and the ethics of their trials in humans.
Veljkovic
Veljko
V
Center for Multidisciplinary Research, Institute of Nuclear Sciences VINCA, Belgrade, Yugoslavia. veljko01@hotmail.com
Prljic
Jelena
J
Veljkovic
Tatjana
T
D016915:AIDS Vaccines / Q000009:adverse effects*; D004666:Encephalitis Virus, Venezuelan Equine / Q000235:genetics; D004992:Ethics, Medical; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D011212:Poxviridae / Q000235:genetics; D012449:Safety; D012475:Salmonella / Q000235:genetics; D018139:Simplexvirus / Q000235:genetics; D014614:Vaccines, Synthetic / Q000276:immunology
D016915:AIDS Vaccines; D015699:HIV Envelope Protein gp120; D014614:Vaccines, Synthetic